Fig. 5From: Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathwaymiR-338-3p attenuated glioma progression by inhibiting THBS1 to inactivate the PI3K/Akt pathwayBack to article page